PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.34%
Revenue growth under 50% of ADI's 13.73%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.44%
Gross profit growth under 50% of ADI's 17.76%. Michael Burry would be concerned about a severe competitive disadvantage.
10.06%
EBIT growth below 50% of ADI's 30.78%. Michael Burry would suspect deeper competitive or cost structure issues.
9.27%
Operating income growth under 50% of ADI's 30.78%. Michael Burry would be concerned about deeper cost or sales issues.
-7.68%
Negative net income growth while ADI stands at 27.05%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.85%
Negative EPS growth while ADI is at 28.57%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.00%
Negative diluted EPS growth while ADI is at 25.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-5.29%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.04%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
8.69%
Dividend growth of 8.69% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-58.68%
Negative OCF growth while ADI is at 0.73%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-152.53%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
43.68%
10Y revenue/share CAGR under 50% of ADI's 263.68%. Michael Burry would suspect a lasting competitive disadvantage.
-12.20%
Negative 5Y CAGR while ADI stands at 217.20%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
14.04%
3Y revenue/share CAGR under 50% of ADI's 125.44%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
322.80%
10Y OCF/share CAGR under 50% of ADI's 656.24%. Michael Burry would worry about a persistent underperformance in cash creation.
57.02%
Below 50% of ADI's 342.73%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
29.13%
3Y OCF/share CAGR under 50% of ADI's 371.07%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2488.56%
Below 50% of ADI's 9359.34%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
66.59%
Below 50% of ADI's 430.29%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
205.05%
3Y net income/share CAGR similar to ADI's 218.63%. Walter Schloss would attribute it to shared growth factors or demand patterns.
261.53%
10Y equity/share CAGR at 75-90% of ADI's 294.28%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
211.41%
5Y equity/share CAGR at 50-75% of ADI's 329.69%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
147.24%
3Y equity/share CAGR similar to ADI's 158.87%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
16.57%
Dividend/share CAGR of 16.57% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
38.50%
Dividend/share CAGR of 38.50% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
2.24%
3Y dividend/share CAGR of 2.24% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
0.10%
AR growth is negative/stable vs. ADI's 13.07%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
4.81%
Inventory growth well above ADI's 0.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
16.45%
Asset growth 1.25-1.5x ADI's 12.21%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
27.76%
BV/share growth above 1.5x ADI's 8.06%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.41%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
18.99%
R&D growth drastically higher vs. ADI's 10.08%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-18.83%
We cut SG&A while ADI invests at 8.04%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.